Alexium International Group Limited · ASX:AJX

Alexium International — H1 FY2024 Earnings Presentation

22 slides from Alexium International's earnings presentation, Feb 27, 2024

  1. Slide 1: FY2024 Half-Year Results

    ALEXIUM INTERNATIONAL GROUP LIMITED FY2024 Half-Year Results 27 February 2024 ABN 91 064 820 408 PRESENTED IN US DOLLARS

  2. Slide 2: Disclaimer

    Disclaimer To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Alexium International Group Limited (Alexium) or any of its related entities or their respective directors or officers, employees, advisors an

  3. Slide 3: Company Overview

    COMPANY OVERVIEW

  4. Slide 4: Company Overview

    Company Overview  A performance materials company leveraging proprietary technical innovations to deliver thermal regulation, dehumidification and flame-retardant solutions.  A pioneer in microencapsulation specialising in phase change materials and innovative composites that offer adaptive therma

  5. Slide 5: Market Segments

    Market Segments  Bedding: flame-retardants and cooling products for mattress and pillow producers  Military: flame-resistant fabrics for uniforms  Industrial: flame resistant fabrics for workwear  Tactical: textiles for cooling for protective gear  Athletics: textiles for cooling in helmets, pa

  6. Slide 6: Alexium's ESG Commitment

    Alexium’s ESG Commitment *By FY25, Alexium will establish baselines, metrics SUSTAINABLE PRODUCT FOCUS: and KPIs for ESG performance: Biocool® | Alexium’s proprietary biobased cooling Environment technology for textile & foam applications  Environment: waste reduction,  Biobased, sustainable raw m

  7. Slide 7: Alexium's Commercialised Product Portfolio

    Alexium’s Commercialised Product Portfolio PCM Comfort Technologies New Comfort Technologies Flame Retardant Technologies  Newest introduction to Alexium’s  Premium PCM cooling for mattress  Customised solutions thermal management product and top of bed portfolio  Designed for use in a variety o

  8. Slide 8: FY24 – 27 Strategic Pathway

    FY24 – 27 Strategic Pathway FY23 FY24 FY25-27 Focus Diversify Profitable Growth  Team : Strengthen the organisation with  Team : Build out direct sales and BD  Team : Bolster operations team, the addition of a new CEO and increased  Culture : Sales and marketing centric mature sales execs focus

  9. Slide 9: FY24 Strategic Priorities

    FY24 Strategic Priorities  Build out and strengthen Alexium’s direct sales and business development team (adding manufacturing reps)  Heightened cash and commercial discipline to improve funding runway and allow investment in key new product/market initiatives  Drive pipeline conversion, and stri

  10. Slide 10: FY24 H1 Highlights

    Alexium is now focused on a simple over-arching strategy: Grow and Diversify Revenue. This strategy ensures that we maintain our share in our core bedding market despite the market headwinds while growing revenue by commercialising our portfolio of technologies into new markets such as footwear, col

  11. Slide 11: FY24 H1 Highlights (cont.)

     Diversify and Grow (continued): o Progress FR Nyco for military. Status: Alexium passed the “Pyroman” burn testing in FY24 H1 then continued development efforts to enhance the aesthetics of the fabric. Next steps will be determined by the Military’s budget for continued testing, which is expected

  12. Slide 12: FY24 H1 Highlights (cont.)

    • Supply Agreements with Major Customers - An initiative within the Company is to enhance the predictable recurring nature of our revenue. We intend to move several of our larger customers from spot purchase or specific-program buying to long-term product supply agreements with defined pricing, supp

  13. Slide 13: FY24 H2 and FY25 Forward Focus

    The near-term focus will be a continuation of converting development opportunities into recurring revenue streams. The strategy deployed in FY23 (Grow and Diversify) is gaining traction and is exemplified in Alexium’s business and product development pipeline, which is full of qualified growth proje

  14. Slide 14: FY24 Financial Overview

    FY24 Financial Overview

  15. Slide 15: Financial Snapshot

    Financial Snapshot  Half-year revenue down 19.5% year over year  Gross Profit was held to a decrease of $68K or 5.2% vs H1 FY23 in spite of revenues being down 19.5%  Gross margin at 44.3% is up 6.7 percentage points from the same period last year due to customer/product mix and manufacturing cos

  16. Slide 16: Financial Spotlights

    Financial Spotlights Profit and Loss  Half-year revenue down 19.5% year over year but gross profit is down only 5.2% due to improved gross margins  Operating expenses down 15.8% or $395K versus prior year Borrowings and Capital Raise  In December, the Company announced its intention to enter a ca

  17. Slide 17: Financial Results

    FINANCIAL RESULTS

  18. Slide 18: Cash Flow Statement

    Cash Flow Statement HY24 HY23 (USD) (USD) • Operating Activities outflows improved $0.8m with changes in: Cash flow from operating activities Recei pts from customers a nd other income 3,257 2,713  $0.5m – cash receipts from higher sales in H2 FY23 Pa yments to suppl i ers a nd empl oyees (3,624) (

  19. Slide 19: Profit & Loss Statement

    Profit & Loss Statement • While revenue has declined $.7m year on year, the business HY24 HY23 % (USD) (USD) Change Change has a strong retention rate of existing customers and has Sales Revenue 2,766 3,435 (669) (19.5%) hired two new business development professionals to drive Cost of Goods Sold (1

  20. Slide 20: Balance Sheet

    Balance Sheet 31-Dec-23 30-Jun-23 (USD) (USD) • Working Capital Current Assets Ca sh a nd ca s h equi va l ents 1,756 513 • Overall net working capital decreased by $0.3m. Trade receivables Tra de a nd other recei va bl es 545 1,047 and inventory were lower due to decreased sales and inventory Inven

  21. Slide 21: Appendix

    APPENDIX

  22. Slide 22: Non-GAAP Financial Measure Reconciliation

    Non-GAAP Financial Measure Reconciliation Reconciliation of Operating EBITDA (non-GAAP financial measure) to statutory Net Profit/(Loss) The consolidated financial statements of the Group are general purpose HY24 HY23 financial statements which have been prepared in accordance with the Australian Ac

Alexium International Group — H1 FY2024 Earnings Presentation on 6ix